Fangfang Shen

Fangfang Shen is a postdoc scholar in Laura Dassama lab at the Department of Chemistry. Before joined Stanford University in Jan 2020, she obtained her Ph.D. at The University of Hong Kong, where her research focused on the development of small molecules to mimic protein functions and their applications as anti-cancer drugs. Currently, her research interest is the identification of novel protein inhibitors as new therapies for blood disorders, including sickle cell disease and beta-thalassemia.